These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2817635)

  • 1. Fluorouracil and palmar-plantar erythrodysesthesia.
    Curran CF; Luce JK
    Ann Intern Med; 1989 Nov; 111(10):858. PubMed ID: 2817635
    [No Abstract]   [Full Text] [Related]  

  • 2. Palmar-plantar erythrodysesthesia and cytarabine.
    Baer MR; King LE; Wolff SN
    Ann Intern Med; 1985 Apr; 102(4):556. PubMed ID: 3977204
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluorouracil and the palmar-plantar erythrodysesthesia syndrome.
    Atkins JN
    Ann Intern Med; 1985 Mar; 102(3):419. PubMed ID: 3155925
    [No Abstract]   [Full Text] [Related]  

  • 4. Penile involvement with hand-foot syndrome.
    Sorscher SM
    Am J Clin Dermatol; 2004; 5(3):209-10. PubMed ID: 15186201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
    Risum S; Langer SW
    Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Painful palmar and plantar erythema associated with hepatic artery infusion of 5-fluoro-2'deoxyuridine.
    Neuss MN; Akwari OE; Stevenson DF; Goodwin BJ
    J Natl Med Assoc; 1987 Jun; 79(6):669-71. PubMed ID: 2956430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmar and plantar erythema due to infusion of sympathomimetics in pregnant women.
    Reygagne P; Lacour JP; Ortonne JP
    Br J Dermatol; 1991 Feb; 124(2):210. PubMed ID: 2004011
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy-induced palmer planter erythrodysesthesia.
    Bhasin S; Sunita ; Gupta DK; Kataria SP; Saluja S; Sharma M
    J Assoc Physicians India; 2005 Feb; 53():155-6. PubMed ID: 15847041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
    Webster-Gandy JD; How C; Harrold K
    Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmar-plantar erythrodysaesthesia and non-pegylated liposomal doxorubicin. A case study.
    Tamayo-Orbegozo E; Iruin-Sanz A; Oñate-Muzás E; Segrelles-Bellmunt G
    Farm Hosp; 2011; 35(1):46-7. PubMed ID: 20619714
    [No Abstract]   [Full Text] [Related]  

  • 11. A variant of the chemotherapy-associated erythrodysesthesia syndrome related to high-dose cyclophosphamide.
    Matsuyama JR; Kwok KK
    DICP; 1989 Oct; 23(10):776, 778-9. PubMed ID: 2815854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.
    Fabian CJ; Molina R; Slavik M; Dahlberg S; Giri S; Stephens R
    Invest New Drugs; 1990 Feb; 8(1):57-63. PubMed ID: 2345070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracycline-induced toxicity affecting palmar and plantar skin.
    Jones AP; Crawford SM
    Br J Cancer; 1989 May; 59(5):814. PubMed ID: 2525400
    [No Abstract]   [Full Text] [Related]  

  • 14. Images in clinical medicine. Palmar-plantar rash with cytarabine therapy.
    Rosenbeck L; Kiel PJ
    N Engl J Med; 2011 Jan; 364(3):e5. PubMed ID: 21247311
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyridoxine as prophylactic therapy for palmar-plantar erythrodysesthesia associated with administration of pegylated liposomal doxorubicin (caelyx): a single-center experience.
    Rossi D; Catalano G
    Oncology; 2007; 73(3-4):277-8. PubMed ID: 18424894
    [No Abstract]   [Full Text] [Related]  

  • 16. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
    Lipworth AD; Robert C; Zhu AX
    Oncology; 2009; 77(5):257-71. PubMed ID: 19923864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatological toxicity from chemotherapy containing 5-fluorouracil.
    Leo S; Tatulli C; Taveri R; Campanella GA; Carrieri G; Colucci G
    J Chemother; 1994 Dec; 6(6):423-6. PubMed ID: 7699432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CDD polymorphism as predictor of capecitabine-induced hand-foot syndrome--letter.
    Ciccolini J; Evrard A; Lacarelle B
    Clin Cancer Res; 2012 Jan; 18(1):317. PubMed ID: 22215908
    [No Abstract]   [Full Text] [Related]  

  • 19. The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy.
    Janusch M; Fischer M; Marsch WCh; Holzhausen HJ; Kegel T; Helmbold P
    Eur J Dermatol; 2006; 16(5):494-9. PubMed ID: 17101468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A woman with palmar and plantar hyperpigmentation].
    van Tienhoven G; Wilmink JW
    Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.